PubRank
Search
About
Timothy Vartanian
Author PubWeight™ 25.42
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway.
Proc Natl Acad Sci U S A
2003
5.11
2
The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS.
J Neurosci
2002
3.55
3
Peroxynitrite generated by inducible nitric oxide synthase and NADPH oxidase mediates microglial toxicity to oligodendrocytes.
Proc Natl Acad Sci U S A
2005
2.30
4
Toll-like receptor 8 functions as a negative regulator of neurite outgrowth and inducer of neuronal apoptosis.
J Cell Biol
2006
2.24
5
Localization of Nogo-A and Nogo-66 receptor proteins at sites of axon-myelin and synaptic contact.
J Neurosci
2002
1.96
6
Toll-like receptor 3 is a potent negative regulator of axonal growth in mammals.
J Neurosci
2007
1.88
7
A mechanism for neurodegeneration induced by group B streptococci through activation of the TLR2/MyD88 pathway in microglia.
J Immunol
2006
1.76
8
Integrin-linked kinase is required for laminin-2-induced oligodendrocyte cell spreading and CNS myelination.
J Cell Biol
2003
1.33
9
Isolation of Clostridium perfringens type B in an individual at first clinical presentation of multiple sclerosis provides clues for environmental triggers of the disease.
PLoS One
2013
1.14
10
TLR8: an innate immune receptor in brain, neurons and axons.
Cell Cycle
2007
1.05
11
The ErbB4 neuregulin receptor mediates suppression of oligodendrocyte maturation.
J Neurosci
2005
1.02
12
A clear and present danger: endogenous ligands of Toll-like receptors.
Neuromolecular Med
2009
0.99
13
Carbon monoxide suppresses membrane expression of TLR4 via myeloid differentiation factor-2 in betaTC3 cells.
J Immunol
2010
0.89
14
Increased expression of epidermal growth factor receptor induces sequestration of extracellular signal-related kinases and selective attenuation of specific epidermal growth factor-mediated signal transduction pathways.
Mol Cancer Res
2003
0.86